Two Sigma Advisers’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-96,300
| Closed | -$488K | – | 2446 |
|
|
2024
Q1 | $488K | Sell |
96,300
-6,600
| -6% | -$33.5K | ﹤0.01% | 1880 |
|
|
2023
Q4 | $289K | Buy |
102,900
+74,700
| +265% | +$210K | ﹤0.01% | 2113 |
|
|
2023
Q3 | $80.9K | Buy |
28,200
+15,400
| +120% | +$44.2K | ﹤0.01% | 2237 |
|
|
2023
Q2 | $64.6K | Sell |
12,800
-163,100
| -93% | -$824K | ﹤0.01% | 2247 |
|
|
2023
Q1 | $332K | Sell |
175,900
-36,600
| -17% | -$69.2K | ﹤0.01% | 2104 |
|
|
2022
Q4 | $383K | Sell |
212,500
-2,100
| -1% | -$3.78K | ﹤0.01% | 1984 |
|
|
2022
Q3 | $363K | Sell |
214,600
-53,500
| -20% | -$90.5K | ﹤0.01% | 1976 |
|
|
2022
Q2 | $660K | Sell |
268,100
-27,500
| -9% | -$67.7K | ﹤0.01% | 1796 |
|
|
2022
Q1 | $819K | Buy |
295,600
+97,100
| +49% | +$269K | ﹤0.01% | 1749 |
|
|
2021
Q4 | $1.06M | Buy |
198,500
+17,200
| +9% | +$91.7K | ﹤0.01% | 1538 |
|
|
2021
Q3 | $1.53M | Buy |
181,300
+97,100
| +115% | +$822K | ﹤0.01% | 1400 |
|
|
2021
Q2 | $1.03M | Buy |
84,200
+41,400
| +97% | +$504K | ﹤0.01% | 1620 |
|
|
2021
Q1 | $1.04M | Buy |
42,800
+11,000
| +35% | +$267K | ﹤0.01% | 1634 |
|
|
2020
Q4 | $1.02M | Buy |
+31,800
| New | +$1.02M | ﹤0.01% | 1560 |
|